Aarti Pharmalabs Limited (NSE: AARTIPHARM)
696.10
+5.30 (0.77%)
Sep 6, 2024, 3:30 PM IST
Aarti Pharmalabs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Cash & Equivalents | - | 239.23 | 121.21 | 832.73 | 2.5 | 2.5 |
Trading Asset Securities | - | 703.94 | 509.9 | - | - | - |
Cash & Short-Term Investments | 943.17 | 943.17 | 631.11 | 832.73 | 2.5 | 2.5 |
Cash Growth | 49.28% | 49.44% | -24.21% | 33209.36% | 0% | - |
Accounts Receivable | - | 5,193 | 4,501 | 3,767 | - | - |
Other Receivables | - | 143.04 | 53.71 | 65.42 | - | - |
Receivables | - | 5,349 | 4,567 | 3,893 | - | - |
Inventory | - | 6,429 | 6,020 | 4,755 | - | - |
Prepaid Expenses | - | 61.48 | 23.25 | 41.96 | - | - |
Other Current Assets | - | 674.18 | 388.04 | 758.89 | - | - |
Total Current Assets | - | 13,456 | 11,630 | 10,281 | 2.5 | 2.5 |
Property, Plant & Equipment | - | 10,932 | 9,861 | 9,453 | - | - |
Long-Term Investments | - | 367.8 | 355.25 | 322.26 | - | - |
Goodwill | - | 17.81 | 17.81 | 17.81 | - | - |
Other Intangible Assets | - | 752.74 | 398.5 | 223.65 | - | - |
Other Long-Term Assets | - | 235.89 | 119.32 | 100.67 | - | - |
Total Assets | - | 25,821 | 22,440 | 20,399 | 2.5 | 2.5 |
Accounts Payable | - | 3,783 | 3,395 | 2,146 | 0.03 | - |
Accrued Expenses | - | 152.57 | 143.44 | 87.83 | - | - |
Short-Term Debt | - | 2,641 | 2,142 | 3,377 | 0.17 | - |
Current Portion of Long-Term Debt | - | - | - | 3.42 | - | - |
Current Portion of Leases | - | 44.91 | 4.45 | 12.44 | - | - |
Current Income Taxes Payable | - | - | 35.15 | 75 | - | - |
Other Current Liabilities | - | 322.59 | 286.65 | 104.8 | 0.02 | - |
Total Current Liabilities | - | 6,944 | 6,006 | 5,807 | 0.22 | - |
Long-Term Debt | - | 0.39 | 1.84 | 5.55 | - | 0.19 |
Long-Term Leases | - | 166.59 | 5.32 | 15.32 | - | - |
Long-Term Deferred Tax Liabilities | - | 1,079 | 788.38 | 706.7 | - | - |
Other Long-Term Liabilities | - | 54.41 | 48.14 | - | - | - |
Total Liabilities | - | 8,251 | 6,855 | 6,534 | 0.22 | 0.19 |
Common Stock | - | 453.13 | 453.13 | 2.5 | 2.5 | 2.5 |
Additional Paid-In Capital | - | 4,403 | 4,403 | 4,403 | - | - |
Retained Earnings | - | 11,734 | 9,746 | 8,006 | -0.22 | -0.19 |
Comprensive Income & Other | - | 979.81 | 982.06 | 1,453 | - | - |
Shareholders' Equity | 17,570 | 17,570 | 15,585 | 13,865 | 2.28 | 2.31 |
Total Liabilities & Equity | - | 25,821 | 22,440 | 20,399 | 2.5 | 2.5 |
Total Debt | 2,853 | 2,853 | 2,153 | 3,414 | 0.17 | 0.19 |
Net Cash (Debt) | -1,909 | -1,909 | -1,522 | -2,581 | 2.33 | 2.31 |
Net Cash Growth | - | - | - | - | 0.59% | - |
Net Cash Per Share | -21.06 | -21.07 | -16.79 | -28.48 | 9.31 | 9.25 |
Filing Date Shares Outstanding | 90.61 | 90.63 | 90.63 | 90.63 | 0.25 | 0.25 |
Total Common Shares Outstanding | 90.61 | 90.63 | 90.63 | 90.63 | 0.25 | 0.25 |
Working Capital | - | 6,513 | 5,624 | 4,475 | 2.28 | 2.5 |
Book Value Per Share | 193.88 | 193.88 | 171.97 | 152.99 | 9.12 | 9.25 |
Tangible Book Value | 16,800 | 16,800 | 15,169 | 13,623 | 2.28 | 2.31 |
Tangible Book Value Per Share | 185.38 | 185.38 | 167.38 | 150.32 | 9.12 | 9.25 |
Land | - | 779.38 | 669.32 | 641.01 | - | - |
Buildings | - | 1,668 | 1,568 | 1,202 | - | - |
Machinery | - | 12,789 | 11,610 | 9,941 | - | - |
Construction In Progress | - | 784.97 | 622.04 | 1,652 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.